title: Attenuated renal production of dopamine in patients with low renin essential hypertension.
abstract: Our previous studies have shown that a suppressed pressure natriuresis may contribute to the hypertensive mechanism in patients with essential hypertension (EHT), particularly in low renin patients (LRH). In this study, in order to clarify the role of renal dopaminergic activity in the blunted natriuresis of LRH, the conversion of 1-dopa (DOPA) to dopamine (DA) in the kidneys was investigated in 9 normotensive subjects (NT) and 20 EHT, including 15 normal renin EHT (NRH) and 5 LRH. All subjects were hospitalized and received a constant diet (Na:120mEq, K:75mEq daily). Plasma DOPA concentration (p-DOPA:HPLC-ECD), creatinine clearance (Ccr), urinary excretion of sodium (UNaV) and DA (UDA), as well as fractional excretion of sodium (FENa) were measured before and after the single oral administration of 1-DOPA (400mg). DOPA administration caused a significant increase of p-DOPA, UDA and FENa with undetectable DOPA levels in the urine in EHT. In addition, under the basal condition, UDA correlated positively with p-DOPA or the product of p-DOPA x Ccr, which might reflect the DOPA delivery at the renal proximal tubule. No significant difference was found in p-DOPA and the product of p-DOPA x Ccr among NT, NRH and LRH. However, the ratio of UDA/(p-DOPA x Ccr), which may indicate the conversion from DOPA to DA in the kidneys, was lower in EHT, especially in LRH, than that in NT. These results suggest that a reduced renal conversion from DOPA to DA may contribute to the attenuated natriuresis as well as renal dopaminergic activity in LRH.
authors.affiliation: Second Department of Internal Medicine, Sapporo Medical College, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Aoki
authors.forename: K
authors.initials: K
authors.lastname: Kikuchi
authors.forename: I
authors.initials: I
authors.lastname: Yamaji
authors.forename: M
authors.initials: M
authors.lastname: Nishimura
authors.forename: C
authors.initials: C
authors.lastname: Honma
authors.forename: H
authors.initials: H
authors.lastname: Kobayakawa
authors.forename: M
authors.initials: M
authors.lastname: Yamamoto
authors.forename: C
authors.initials: C
authors.lastname: Kudoh
authors.forename: M
authors.initials: M
authors.lastname: Shimazaki
authors.forename: T
authors.initials: T
authors.lastname: Sakamoto
mesh_terms: D000293:Adolescent; D000328:Adult; D004298:Dopamine / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D007980:Levodopa / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012083:Renin / Q000097:blood*
chemical_list: D007980:Levodopa; D012083:Renin; D004298:Dopamine